Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
Chinese Clinical Trial Registry: ChiCTR2000029757.
Publications
2 shownCombined FXIII-C3 autoantibodies elicit bleeding and complement dysfunction in autoimmune FXIII deficiency
Autoimmune factor XIII (FXIII) deficiency is a rare hemorrhagic disease characterized by severe bleeding and a high mortality rate. However, the pathogenesis of this disease rem...
Frequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 2
- Citations
- 1,292
- Institution
- Huazhong University of Science and Technology
External Links
Identifiers
- ORCID
- 0000-0001-7941-2443
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.